The Tobacco Control Scale 2025 shows that progress in tobacco control across Europe has slowed, with more countries recording lower scores than in previous years. Key reasons include the failure to regulate heated tobacco products in the...
The UNODC Early Warning Advisory highlights a continued global expansion of new psychoactive substances (NPS), with nearly 1,400 substances reported worldwide. In 2024 alone, a record number of substances were identified, including over 100...
This report highlights a growing concern around stimulant use and related harms in Canada, particularly involving cocaine and methamphetamine. Data from multiple national sources show that stimulant-related deaths have significantly...
The European Union Drugs Agency has released updated data sheets providing a clear and comparable overview of drug-related indicators across six Western Balkan partners under the Instrument for Pre-accession Assistance (IPA). These include...
This issue is the second of a special two-part series. Part 2 examines key factors driving stimulant use, what these trends mean for different groups of people and the responses being implemented to reduce harms.
Three key points of...
This issue is a special two-part series. The first part features a regional breakdown of reports from seven Canadian Community Epidemiology Network on Drug Use (CCENDU) nodes and five drug checking services from across the country. It...
School suspension in adolescence has been shown to predict homelessness in young adulthood, suggesting that it may be a point of intervention to reduce young adult homelessness. Under zero tolerance policies, school suspension is more...
Secondhand smoke (SHS) continues to be a major global health risk, contributing to cardiovascular diseases, metabolic disorders, and respiratory illnesses. Using data from the Global Burden of Disease 2021 study across 204 countries, this...
Artificial intelligence (AI) is transforming how we understand and manage substance use disorders (SUDs). The following curated readings highlight current developments, practical applications, and ethical considerations for AI in this field...
The article explores how artificial intelligence (AI) is currently used — and could be used — in the field of addiction research and treatment. The authors note that AI (machine learning, data mining, predictive analytics) offers...
The study examines whether artificial intelligence can reliably predict the use of specific substances in Finland, including cannabis, ecstasy, amphetamine, cocaine and non-prescribed medicines. Using data from the 2022 Finnish National...
The Canadian Centre on Substance Use and Addiction (CCSA) transforms complex data into insights that reflect real human experiences. Every aspect of the Canadian Substance Use Cost and Harms (CSUCH) project represents individuals with lived...
Background
Smoking is more common in lower socioeconomic position (SEP) groups, but smoking cessation interventions are less effective for these groups. StopCoach, an mHealth intervention, supports people with lower SEP in quitting smoking...
Background
The opioid epidemic continues to pose significant challenges in the United States, with over 75% of nearly 107,000 drug overdose deaths in 2022 involving opioids. Recently, efforts to curb the epidemic have made strides...
Background
Smoking is one of the top causes of preventable death and is linked to many serious health problems, including cancer and chronic diseases. Nurses can play a big role in helping people quit smoking by offering support through...
